Raffles Medical Group Ltd (FRA:02M1)

Raffles Medical Group Statistics

Total Valuation

FRA:02M1 has a market cap or net worth of EUR 1.29 billion. The enterprise value is 1.14 billion.

Market Cap	1.29B
Enterprise Value	1.14B

Important Dates

The last earnings date was Monday, July 28, 2025.

Earnings Date	Jul 28, 2025
Ex-Dividend Date	May 13, 2025

Share Statistics

Current Share Class	1.85B
Shares Outstanding	n/a
Shares Change (YoY)	-1.15%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	782.25M

Valuation Ratios

The trailing PE ratio is 30.36 and the forward PE ratio is 28.24.

PE Ratio	30.36
Forward PE	28.24
PS Ratio	2.53
PB Ratio	1.87
P/TBV Ratio	1.93
P/FCF Ratio	19.76
P/OCF Ratio	17.86
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.46, with an EV/FCF ratio of 17.42.

EV / Earnings	26.76
EV / Sales	2.23
EV / EBITDA	13.46
EV / EBIT	20.01
EV / FCF	17.42

Financial Position

The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.09.

Current Ratio	1.19
Quick Ratio	1.17
Debt / Equity	0.09
Debt / EBITDA	0.70
Debt / FCF	0.90
Interest Coverage	17.97

Financial Efficiency

Return on equity (ROE) is 6.18% and return on invested capital (ROIC) is 4.72%.

Return on Equity (ROE)	6.18%
Return on Assets (ROA)	3.55%
Return on Invested Capital (ROIC)	4.72%
Return on Capital Employed (ROCE)	7.97%
Revenue Per Employee	176,439
Profits Per Employee	14,690
Employee Count	2,989
Asset Turnover	0.51
Inventory Turnover	36.57

Taxes

In the past 12 months, FRA:02M1 has paid 15.81 million in taxes.

Income Tax	15.81M
Effective Tax Rate	27.04%

Stock Price Statistics

The stock price has increased by +14.78% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+14.78%
50-Day Moving Average	0.64
200-Day Moving Average	0.61
Relative Strength Index (RSI)	65.11
Average Volume (20 Days)	89

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:02M1 had revenue of EUR 511.67 million and earned 42.60 million in profits. Earnings per share was 0.02.

Revenue	511.67M
Gross Profit	233.13M
Operating Income	57.12M
Pretax Income	58.49M
Net Income	42.60M
EBITDA	77.76M
EBIT	57.12M
Earnings Per Share (EPS)	0.02

Balance Sheet

The company has 223.47 million in cash and 59.20 million in debt, giving a net cash position of 164.27 million.

Cash & Cash Equivalents	223.47M
Total Debt	59.20M
Net Cash	164.27M
Net Cash Per Share	n/a
Equity (Book Value)	691.96M
Book Value Per Share	0.37
Working Capital	54.40M

Cash Flow

In the last 12 months, operating cash flow was 72.41 million and capital expenditures -6.98 million, giving a free cash flow of 65.43 million.

Operating Cash Flow	72.41M
Capital Expenditures	-6.98M
Free Cash Flow	65.43M
FCF Per Share	n/a

Margins

Gross margin is 45.56%, with operating and profit margins of 11.16% and 8.33%.

Gross Margin	45.56%
Operating Margin	11.16%
Pretax Margin	11.43%
Profit Margin	8.33%
EBITDA Margin	15.20%
EBIT Margin	11.16%
FCF Margin	12.79%

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 2.46%.

Dividend Per Share	0.02
Dividend Yield	2.46%
Dividend Growth (YoY)	4.74%
Years of Dividend Growth	n/a
Payout Ratio	72.63%
Buyback Yield	1.15%
Shareholder Yield	3.61%
Earnings Yield	3.29%
FCF Yield	5.06%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:02M1 has an Altman Z-Score of 3.59 and a Piotroski F-Score of 7.

Altman Z-Score	3.59
Piotroski F-Score	7